WHO: Under 5% of Genomic Studies in Low-Middle Income Nations

A new WHO analysis reveals that less than 5% of disease-focused genomic studies globally are conducted in low and middle-income countries, while over 80% are concentrated in high-income nations. This disparity highlights a significant gap in addressing global health priorities.

• Less than 5% of global genomic studies are in low-middle income countries.
• Over 80% of disease-focused genomic studies are concentrated in high-income nations.
• The WHO analysis registered over 6,500 studies between 1990 and 2024.
• China, US, and Italy lead in genomic studies; India is among the top 20.
• Most studies focus on cancer and rare diseases, neglecting infectious diseases.
• Significant demographic gaps exist, with few studies on children or older adults.

Read the full story on Quick Digest.